All In MedTech

Device Trial Radar · NCT03073265

Apixaban Validation Study - Additional Study on Fresh Samples

Validation Study Protocol - Additional Study on Fresh Samples STA - Apixaban Calibrator & STA - Apixaban Control

Last checked: Nov 20, 2026Latest source record: Mar 9, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

109

Actual

Start

May 8, 2017

Primary completion

Nov 1, 2017

Study completion Nov 1, 2017

Sponsor

Lead sponsor
Diagnostica StagoNot on our public-company list
Sponsor type
Industry
First posted
Mar 8, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective is to demonstrate the performances of STA® - Apixaban Calibrator \& STA® - Apixaban Control used in combination with STA® - Liquid Anti-Xa to measure apixaban concentration in plasma. Anti-Xa results will be compared to LCMS (liquid chromatography - mass spectrometry) for validation of the assay. For this study, the anti-Xa assay will be performed on fresh samples only. The results will be used to complete results obtained previously on frozen samples.

Conditions

  • Anticoagulation With Apixaban

Interventions

  • STA-Apixaban Calibrator & ControlDevice

    Measurement of apixaban level will be done using anti-Xa assay (IVD).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Method comparison between Anti-Xa method and LCMS to measure apixaban in plasmaTime frame: The anti-Xa assay will be tested within 6h after sample collection and LCMS will be performed on frozen samples, at maximum 2 months after collection.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Moses Cone Memorial Hospital

    Greensboro, North Carolina

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.